Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

NLRX1 does not inhibit MAVS-dependent antiviral signalling.

Soares F, Tattoli I, Wortzman ME, Arnoult D, Philpott DJ, Girardin SE.

Innate Immun. 2013;19(4):438-48. doi: 10.1177/1753425912467383. Epub 2012 Dec 4.

PMID:
23212541
2.

NLRX1 is a regulator of mitochondrial antiviral immunity.

Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, Zimmermann AG, Accavitti-Loper MA, Madden VJ, Sun L, Ye Z, Lich JD, Heise MT, Chen Z, Ting JP.

Nature. 2008 Jan 31;451(7178):573-7. doi: 10.1038/nature06501. Epub 2008 Jan 16.

PMID:
18200010
3.

NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathways.

Allen IC, Moore CB, Schneider M, Lei Y, Davis BK, Scull MA, Gris D, Roney KE, Zimmermann AG, Bowzard JB, Ranjan P, Monroe KM, Pickles RJ, Sambhara S, Ting JP.

Immunity. 2011 Jun 24;34(6):854-65. doi: 10.1016/j.immuni.2011.03.026.

4.

NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein.

Jaworska J, Coulombe F, Downey J, Tzelepis F, Shalaby K, Tattoli I, Berube J, Rousseau S, Martin JG, Girardin SE, McCullers JA, Divangahi M.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):E2110-9. doi: 10.1073/pnas.1322118111. Epub 2014 May 5.

5.

A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response.

Paz S, Vilasco M, Werden SJ, Arguello M, Joseph-Pillai D, Zhao T, Nguyen TL, Sun Q, Meurs EF, Lin R, Hiscott J.

Cell Res. 2011 Jun;21(6):895-910. doi: 10.1038/cr.2011.2. Epub 2011 Jan 4.

7.

Suppression of NLRX1 in chronic obstructive pulmonary disease.

Kang MJ, Yoon CM, Kim BH, Lee CM, Zhou Y, Sauler M, Homer R, Dhamija A, Boffa D, West AP, Shadel GS, Ting JP, Tedrow JR, Kaminski N, Kim WJ, Lee CG, Oh YM, Elias JA.

J Clin Invest. 2015 Jun;125(6):2458-62. doi: 10.1172/JCI71747. Epub 2015 May 4.

8.

TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses.

López CB, Moltedo B, Alexopoulou L, Bonifaz L, Flavell RA, Moran TM.

J Immunol. 2004 Dec 1;173(11):6882-9.

9.

Negative regulation of MAVS-mediated innate immune response by PSMA7.

Jia Y, Song T, Wei C, Ni C, Zheng Z, Xu Q, Ma H, Li L, Zhang Y, He X, Xu Y, Shi W, Zhong H.

J Immunol. 2009 Oct 1;183(7):4241-8. doi: 10.4049/jimmunol.0901646. Epub 2009 Sep 4.

10.

Modulation of Innate Immune Signalling by Lipid-Mediated MAVS Transmembrane Domain Oligomerization.

Nobre L, Wise D, Ron D, Volmer R.

PLoS One. 2015 Aug 28;10(8):e0136883. doi: 10.1371/journal.pone.0136883. eCollection 2015.

11.

PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4.

You F, Sun H, Zhou X, Sun W, Liang S, Zhai Z, Jiang Z.

Nat Immunol. 2009 Dec;10(12):1300-8. doi: 10.1038/ni.1815. Epub 2009 Nov 1.

PMID:
19881509
12.

TRAF5 is a downstream target of MAVS in antiviral innate immune signaling.

Tang ED, Wang CY.

PLoS One. 2010 Feb 11;5(2):e9172. doi: 10.1371/journal.pone.0009172.

13.

FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.

Abdul-Careem MF, Firoz Mian M, Gillgrass AE, Chenoweth MJ, Barra NG, Chan T, Al-Garawi AA, Chew MV, Yue G, van Roojen N, Xing Z, Ashkar AA.

Antiviral Res. 2011 Nov;92(2):346-55. doi: 10.1016/j.antiviral.2011.09.004. Epub 2011 Sep 14.

PMID:
21945041
14.

Characterization of three Nod-like receptors and their role in antimicrobial responses of goldfish (Carassius auratus L.) macrophages to Aeromonas salmonicida and Mycobacterium marinum.

Xie J, Hodgkinson JW, Katzenback BA, Kovacevic N, Belosevic M.

Dev Comp Immunol. 2013 Mar;39(3):180-7. doi: 10.1016/j.dci.2012.11.005. Epub 2012 Nov 27.

PMID:
23194927
15.

The specific and essential role of MAVS in antiviral innate immune responses.

Sun Q, Sun L, Liu HH, Chen X, Seth RB, Forman J, Chen ZJ.

Immunity. 2006 May;24(5):633-42.

16.

Innate immunity: squelching anti-viral signalling with NLRX1.

O'Neill LA.

Curr Biol. 2008 Apr 8;18(7):R302-4. doi: 10.1016/j.cub.2008.02.021.

17.

NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production.

Tattoli I, Carneiro LA, Jéhanno M, Magalhaes JG, Shu Y, Philpott DJ, Arnoult D, Girardin SE.

EMBO Rep. 2008 Mar;9(3):293-300. doi: 10.1038/sj.embor.7401161. Epub 2008 Jan 25.

18.

Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination.

Koyama S, Ishii KJ, Kumar H, Tanimoto T, Coban C, Uematsu S, Kawai T, Akira S.

J Immunol. 2007 Oct 1;179(7):4711-20.

19.

MAVS-MKK7-JNK2 defines a novel apoptotic signaling pathway during viral infection.

Huang Y, Liu H, Li S, Tang Y, Wei B, Yu H, Wang C.

PLoS Pathog. 2014 Mar 20;10(3):e1004020. doi: 10.1371/journal.ppat.1004020. eCollection 2014 Mar.

20.

Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity.

Tapia K, Kim WK, Sun Y, Mercado-López X, Dunay E, Wise M, Adu M, López CB.

PLoS Pathog. 2013 Oct;9(10):e1003703. doi: 10.1371/journal.ppat.1003703. Epub 2013 Oct 31.

Supplemental Content

Support Center